Brain Stimulation Using TMS to Treat Anxiety and Depression in Children and Youth Ages 6 to 18

What this Trial Is About

Researchers are evaluating whether transcranial magnetic stimulation TMS can improve anxiety and depression symptoms in children and youth aged 6 to 18 years who have been referred by physicians. This open-label trial focuses on mental health disorders, which affect a significant number of young people and impact their daily functioning and quality of life. The study aims to explore TMS as a non-pharmaceutical treatment option, given the limitations and side effects of current therapies and the growing need for alternative approaches in this population. Participants will receive active TMS treatment based on their referral and individual presentation. The treatment involves using non-invasive brain stimulation to influence neural activity, with sessions conducted over a 5-week period. This study does not include a placebo group and focuses solely on the effects of TMS in youth with anxiety or depression. The therapy is monitored closely to assess its impact and tolerability in this age group. During the study, participants will undergo various assessments at the start and after 5 weeks, including anxiety and depression scales, quality of life questionnaires, cognitive tests, and measures of emotional regulation and behavioral symptoms. Researchers will monitor treatment adherence and safety throughout the trial. The primary outcome is the Revised Children Anxiety and Depression Scale RCADS, evaluated at baseline and after 5 weeks. The total participation involves these assessments and TMS sessions over the 5-week treatment period.

Brain STimulation for ANxiety and Depression in Youth